Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie und Endokrinologie
Welcome,         Profile    Billing    Logout  
 5 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cornberg, Markus
NCT03866187: Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Active, not recruiting
1/2
148
Europe, RoW
ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation, HBc-HBs/AS01B-4 low dose formulation, HBc-HBs/AS01B-4 high dose formulation, MVA-HBV low dose formulation, MVA-HBV high dose formulation, Placebo
GlaxoSmithKline
Hepatitis B, Chronic
10/25
10/25
NCT03643172 / 2011-003523-35: Terminator 2 Register

Recruiting
N/A
50
Europe
Hannover Medical School, German Center for Infection Research
Chronic Hepatitis B, HBeAg Negative
07/20
07/24
HDV750, NCT06160635: D-SOLVE Cohorts (Cohort A and B)

Recruiting
N/A
750
Europe
Hannover Medical School, Karolinska University Hospital, Karolinska Institutet, Helmholtz Centre for Infection Research, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, National Institute of Infectious Diseases Matei Bals
HDV, HDV Infection, Chronic Liver Disease
09/26
09/26
NCT05051098: A Non-interventional Registry for Patients With Hepatitis B Virus Infection

Recruiting
N/A
3000
Europe
No intervention
Hannover Medical School, European Union, German Center for Infection Research, German Liver Foundation (DLS)
Hepatitis B Virus Infection
12/24
12/25

Download Options